Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: JF Quinnelly who wrote (839)	3/16/1999 7:17:00 PM
From: lnkennedy	Read Replies (1) \| Respond to of 1728

No 20's, but someone is getting a deal.http://www.go2net.newsalert.com/bin/story?StoryId=CnUYt0bWbu0znmteZ&FQ=c%25affx%20&Title=Headlines%20for%3A%20affx%0A I see in the news generically, that great progress is being made on the genome project. Results are faster than predicted and accuracy of screening is higher than expected. Rightly or not I assume the NIH project is using AFFX product and that Elmer-Perkin is competing w/ INCYTE. Is this correct,news here is slow and I can't keep it straight always. Looking forward to a steady rise once the project is completed early next year, way ahead of schedule. lnk